Safety and efficacy of alfuzosin 10 mg once-daily in the treatment of lower urinary tract symptoms and clinical benign prostatic hyperplasia: a pooled analysis of three double-blind, placebo-controlled studies - Reply

被引:0
|
作者
Roehrborn, CG [1 ]
机构
[1] Univ Texas, SW Med Ctr, Dept Urol, Dallas, TX 75230 USA
关键词
D O I
10.1111/j.1464-410X.2003.4537b.x
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:1044 / 1045
页数:2
相关论文
共 50 条
  • [41] A randomised, placebo-controlled study to assess the efficacy of twice-daily vardenafil in the treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia
    Stief, Christian G.
    Porst, Hartmut
    Neuser, Dieter
    Beneke, Manfred
    Ulbrich, Ernst
    EUROPEAN UROLOGY, 2008, 53 (06) : 1236 - 1244
  • [43] Impact of cardiovascular risk factors and related comorbid conditions and medical therapy reported at baseline on the treatment response to tadalafil 5mg once-daily in men with lower urinary tract symptoms associated with benign prostatic hyperplasia: an integrated analysis of four randomised, double-blind, placebo-controlled, clinical trials
    Vlachopoulos, C.
    Oelke, M.
    Maggi, M.
    Mulhall, J. P.
    Rosenberg, M. T.
    Brock, G. B.
    Esler, A.
    Buettner, H.
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2015, 69 (12) : 1496 - 1507
  • [44] Response to daily 10 Mg alfuzosin predicts acute urinary retention and benign prostatic hyperplasia related surgery in men with lower urinary tract symptoms
    Emberton, Mark
    Lukacs, Bertrand
    Matzkin, Haim
    Alcaraz, Antonio
    Elhilali, Mostafa
    Vallancien, Guy
    JOURNAL OF UROLOGY, 2006, 176 (03): : 1051 - 1056
  • [45] Evaluation of efficacy of cholecalciferol and silymarin in improving lower urinary tract symptoms of benign prostatic hyperplasia: A double-blind, randomized, controlled trial
    Valipour, Reza
    Narouie, Behzad
    Momeni, Hamidreza
    Radpour, Negar
    Torabinavid, Parham
    Momeni, Amirreza
    Jowzi, Ali
    UROLOGIA JOURNAL, 2024, 91 (04) : 727 - 737
  • [46] BOTULINUM TOXIN TYPE A IN THE MANAGEMENT OF LOWER URINARY TRACT SYMPTOMS DUE TO BENIGN PROSTATIC HYPERPLASIA: PRELIMINARY RESULTS OF A RANDOMIZED, PLACEBO-CONTROLLED, DOUBLE-BLIND STUDY
    Sacco, E.
    Totaro, A.
    Vittori, M.
    Tienforti, D.
    Pinto, F.
    D'Addessi, A.
    Racioppi, M.
    Gulino, G.
    Volpe, A.
    Bassi, P.
    EUROPEAN UROLOGY SUPPLEMENTS, 2011, 10 (02) : 151 - 151
  • [47] Safety and efficacy of the combination of once-daily tadalafil and alpha-1 blocker in Japanese men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia: A randomized, placebo-controlled, cross-over study
    Takeda, Masayuki
    Yokoyama, Osamu
    Yoshida, Masaki
    Nishizawa, Osamu
    Hirata, Kinya
    Nakaoka, Ryuhei
    Takita, Yasushi
    Murakami, Masahiro
    INTERNATIONAL JOURNAL OF UROLOGY, 2017, 24 (07) : 539 - 547
  • [48] EFFICACY FOR ERECTILE FUNCTION AND LOWER URINARY TRACT SYMPTOMS OF MIRODENAFIL 50 MG ONCE DAILY IN PATIENTS WITH ERECTILE DYSFUNCTION: A MULTICENTER, RANDOMISED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL
    Chung, Jae Hoon
    Oh, Cheol Young
    Moon, Kyung Hyun
    Kim, Tae Hyo
    Chung, Jae Min
    Park, Jinsung
    Cho, Hee Joo
    Cho, Jeong Man
    Yoo, Tag Keun
    Lee, Wan
    Lee, Ki Soo
    Lee, Seung Wook
    JOURNAL OF UROLOGY, 2012, 187 (04): : E600 - E601
  • [49] EFFECT OF TADALAFIL ONCE DAILY ON PROSTATE BLOOD FLOW AND PERFUSION IN MEN WITH LOWER URINARY TRACT SYMPTOMS SECONDARY TO BENIGN PROSTATIC HYPERPLASIA (BPH-LUTS): A RANDOMIZED, DOUBLE-BLIND, MULTICENTER, PLACEBO-CONTROLLED TRIAL
    Pinggera, G.
    Frauscher, F.
    Paduch, D. A.
    Bolyakov, A.
    Efros, M.
    Kaminetsky, J.
    Da Pozzo, L.
    Esler, A.
    Cox, D.
    JOURNAL OF SEXUAL MEDICINE, 2013, 10 : 252 - 252
  • [50] THE LONG-TERM SAFETY AND EFFICACY OF TADALAFIL 5MG ONCE-DAILY IN MEN WITH LOWER URINARY TRACT SYMPTOMS SECONDARY TO BENIGN PROSTATIC HYPERPLASIA (BPH-LUTS)
    Donatucci, C.
    Brock, G.
    Goldfischer, E.
    Pommerville, P.
    Elion-Mboussa, A.
    Kissel, J.
    Viktrup, L.
    EUROPEAN UROLOGY SUPPLEMENTS, 2010, 9 (02) : 312 - 312